GlassScriptPhysician profile
Nathan R Roberts
NPI 1942526165
$4,754.10
in general payments reported to CMS, 2019-2025
44 companies · $949 in 2025
The $949 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $108 · 2021: $502 · 2022: $509 · 2023: $1,143 · 2024: $940 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,932 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,932.09 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $898.06 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $496.80 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Procept Biorobotics Corporation | $353.43 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Antares Pharma, INC. | $248.90 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Sumitomo Pharma America, INC. | $241.91 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $176.81 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $151.02 | 2019-2025 | Adstiladrin |
| Tempus Ai, INC | $147.39 | 2024 | Xt Cdx |
| Boston Scientific Corporation | $146.52 | 2019-2025 | Spaceoar Vue System - 10ml |
| Axonics, INC. | $141.03 | 2022 | |
| Olympus America INC. | $130.53 | 2021-2023 | Itind System |
| Neotract INC. | $126.02 | 2019-2020 | |
| Secura Bio, INC. | $122.13 | 2024 | Copiktra |
| Laborie Medical Technologies Corp. | $101.83 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| C. R. Bard, INC. & Subsidiaries | $93.35 | 2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $90.47 | 2023-2025 | Jelmyto |
| Allergan, INC. | $80.81 | 2019-2021 | |
| Renovia INC | $79.19 | 2019 | |
| Blue Earth Diagnostics | $78.80 | 2023-2024 | |
| Coloplast Corp | $78.77 | 2023-2024 | Speedicath |
| Dendreon Pharmaceuticals LLC | $67.17 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.64 | 2021-2025 | |
| Tolmar, INC. | $52.33 | 2024-2025 | Eligard, Jatenzo |
| Abbvie INC. | $50.62 | 2019-2023 | Botox |
| Urovant Sciences INC | $49.68 | 2021-2022 | |
| Hollister Incorporated | $48.21 | 2023-2024 | Infyna Chic, Vapro Pocket |
| Teleflex LLC | $47.56 | 2024-2025 | Urolift |
| Progenics Pharmaceuticals, INC. | $40.20 | 2023 | Pylarify |
| Accord Healthcare, INC. | $36.64 | 2023-2024 | |
| Clarus Therapeutics INC. | $35.02 | 2021 | |
| Immunitybio, INC. | $34.52 | 2024 | |
| Halozyme INC | $27.71 | 2023 | |
| Lantheus Medical Imaging, INC. | $27.71 | 2024 | |
| Bioprotect Medical, INC. | $27.56 | 2025 | Bioprotect Balloon Implant System |
| Convatec INC. | $26.24 | 2022 | |
| Mallinckrodt Hospital Products INC. | $18.88 | 2023 | Uvadex |
| Endo Pharmaceuticals INC. | $18.44 | 2019 | |
| Rochester Medical Corporation | $18.29 | 2021 | |
| Palette Life Sciences, INC. | $17.85 | 2022 | |
| Dentsply Ih Ab | $17.70 | 2025 | Lofric |
| Photocure INC | $17.48 | 2019 | |
| Baxter Healthcare | $12.30 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Covidien LP | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.